Disordered zonal and cellular CYP11B2 enzyme expression in familial hyperaldosteronism type 3.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 27793677)

Published in Mol Cell Endocrinol on October 25, 2016

Authors

Celso E Gomez-Sanchez1, Xin Qi2, Elise P Gomez-Sanchez3, Hironobu Sasano4, Martin O Bohlen5, Max Wisgerhof6

Author Affiliations

1: Endocrinology Division, G.V. (Sonny) Montgomery VA Medical Center, Jackson, MS, United States; University of Mississippi Medical Center, Jackson, MS, United States. Electronic address: cgomez-sanchez@umc.edu.
2: University of Mississippi Medical Center, Jackson, MS, United States.
3: Department of Pharmacology and Toxicology and Medicine, University of Mississippi Medical Center, Jackson, MS, United States.
4: Department of Pathology, Tohoku University, Sendai, Japan.
5: Department of Anatomical Sciences, University of Mississippi Medical Center, Jackson, MS, United States.
6: Division of Endocrinology, Henry Ford Health System, Detroit, MI, United States.

Articles citing this

Familial hyperaldosteronism type III. J Hum Hypertens (2017) 0.75

Articles cited by this

K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science (2011) 5.40

Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome. J Lab Clin Med (1955) 4.35

A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature (1992) 3.40

A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab (2008) 2.48

[Constitution of aldosterone, a new mineralocorticoid]. Experientia (1954) 2.28

Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis. Endocrinology (2012) 2.27

[Isolation from the adrenals of a new crystalline hormone with especially high effectiveness on mineral metabolism]. Experientia (1953) 1.80

Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5. Proc Natl Acad Sci U S A (2012) 1.74

18-oxocortisol measurement in adrenal vein sampling as a biomarker for subclassifying primary aldosteronism. J Clin Endocrinol Metab (2011) 1.54

KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism. Hypertension (2011) 1.51

Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors. J Clin Endocrinol Metab (2012) 1.50

Development of monoclonal antibodies against human CYP11B1 and CYP11B2. Mol Cell Endocrinol (2013) 1.40

Isolation of a highly active mineralocorticoid from beef adrenal extract. Nature (1952) 1.33

A novel point mutation in the KCNJ5 gene causing primary hyperaldosteronism and early-onset autosomal dominant hypertension. J Clin Endocrinol Metab (2012) 1.20

Diagnosis of primary aldosteronism: from screening to subtype differentiation. Trends Endocrinol Metab (2005) 1.19

Adrenarche results from development of a 3beta-hydroxysteroid dehydrogenase-deficient adrenal reticularis. J Clin Endocrinol Metab (1998) 1.07

A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22). J Med Genet (2000) 1.07

a Novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III. J Clin Endocrinol Metab (2013) 1.05

Role for germline mutations and a rare coding single nucleotide polymorphism within the KCNJ5 potassium channel in a large cohort of sporadic cases of primary aldosteronism. Hypertension (2014) 1.03

Familial hyperaldosteronism type II: five families with a new variety of primary aldosteronism. Clin Exp Pharmacol Physiol (1992) 1.03

Primary aldosteronism due to adrenal hyperplasia; occurrence in a boy aged 10 years. AMA J Dis Child (1959) 0.96

New insights into aldosterone-producing adenomas and hereditary aldosteronism: mutations in the K+ channel KCNJ5. Curr Opin Nephrol Hypertens (2013) 0.94

Elevated urinary excretion of 18-oxocortisol in glucocorticoid-suppressible aldosteronism. J Clin Endocrinol Metab (1984) 0.94

18-hydroxycorticosterone, 18-hydroxycortisol, and 18-oxocortisol in the diagnosis of primary aldosteronism and its subtypes. J Clin Endocrinol Metab (2012) 0.92

The potassium channel, Kir3.4 participates in angiotensin II-stimulated aldosterone production by a human adrenocortical cell line. Endocrinology (2012) 0.92

Adrenal CYP11B1/2 expression in primary aldosteronism: immunohistochemical analysis using novel monoclonal antibodies. Mol Cell Endocrinol (2014) 0.91

Biosynthesis of 18-oxocortisol by aldosterone-producing adrenal tissue. J Biol Chem (1983) 0.89

Human adrenal cells that express both 3β-hydroxysteroid dehydrogenase type 2 (HSD3B2) and cytochrome b5 (CYB5A) contribute to adrenal androstenedione production. J Steroid Biochem Mol Biol (2010) 0.84

Hypersecretion of a new corticosteroid, 18-hydroxycortisol in two types of adrenocortical hypertension. Clin Exp Hypertens A (1982) 0.81

Studies on the origin of circulating 18-hydroxycortisol and 18-oxocortisol in normal human subjects. J Clin Endocrinol Metab (2004) 0.79